Market Update (NASDAQ:CELG): Celgene Corporation Commences Tender Offer for Receptos, Inc.

[Business Wire] – Celgene Corporation today announced that its direct wholly-owned subsidiary, Strix Corporation, has commenced its previously announced tender offer for all outstanding shares of common stock of Receptos, Inc. Read more . . . → Read More: Market Update (NASDAQ:CELG): Celgene Corporation Commences Tender Offer for Receptos, Inc. Similar Articles: Market Update: Celgene Corporation (NASDAQ:CELG) – Celgene Corporation to Webcast at Upcoming Investor Conferences in June Company Update (NASDAQ:CELG): Celgene Announces Presentations of Investigational Studies in Solid Tumor and Blood Cancers at ASCO 2015 Company Update: Celgene Corporation (NASDAQ:CELG) – Phase II Data for Celgene’s Investigational Oral GED-0301 for Patients with Active Crohn’s Disease Published in New England Journal of Medicine